Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, March 29, 2024 | Back issues
Courthouse News Service Courthouse News Service

Generic Drugmakers

Hoping to represent a class of direct purchasers of propranolol, the generic version of the beta-blocker Inderal, FWK Holdings accuses 10 drugmakers of fixing prices.

MANHATTAN – Hoping to represent a class of direct purchasers of propranolol, the generic version of the beta-blocker Inderal, FWK Holdings accuses 10 drugmakers of fixing prices. The defendants include Actavis Elizabeth, Teva Pharmaceuticals, Mylan, Par Pharmaceuticals and Heritage Pharmaceuticals.

Follow @bleonardcns
Categories / Business, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...